|
1
|
Kaaks R, Lukanova A and Kurzer MS:
Obesity, endogenous hormones, and endometrial cancer risk: a
synthetic review. Cancer Epidemiol Biomarkers Prev. 11:1531–1543.
2002.PubMed/NCBI
|
|
2
|
Salazar EL, Paredes A and Calzada L:
Endometrial thickness of postmenopausal breast cancer patients
treated with tamoxifen. Gynecol Endocrinol. 21:312–316. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu FS: Molecular carcinogenesis of
endometrial cancer. Taiwan J Obstet Gynecol. 46:26–32. 2007.
View Article : Google Scholar
|
|
5
|
Merritt MA and Cramer DW: Molecular
pathogenesis of endometrial and ovarian cancer. Cancer Biomark.
9:287–305. 2010.PubMed/NCBI
|
|
6
|
Kim JW, Kim SH, Kim YT and Kim DK:
Clinicopathologic and biological parameters predicting the
prognosis in endometrial cancer. Yonsei Med J. 43:769–778. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aqeilan RI, Kuroki T, Pekarsky Y, et al:
Loss of WWOX expression in gastric carcinoma. Clin Cancer Res.
10:3053–3058. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen T, Sahin A and Aldaz CM: Deletion map
of chromosome 16q in ductal carcinoma in situ of the breast:
refining a putative tumor suppressor gene region. Cancer Res.
56:5605–5609. 1996.PubMed/NCBI
|
|
9
|
Kosla K, Pluciennik E, Kurzyk A, et al:
Molecular analysis of WWOX expression correlation with
proliferation and apoptosis in glioblastoma multiforme. J
Neurooncol. 101:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nunez MI, Rosen DG, Ludes-Meyers JH, et
al: WWOX protein expression varies among ovarian carcinoma
histotypes and correlates with less favorable outcome. BMC Cancer.
5:642005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pluciennik E, Kusinska R, Potemski P,
Kubiak R, Kordek R and Bednarek AK: WWOX - the FRA16D cancer gene:
expression correlation with breast cancer progression and
prognosis. Eur J Surg Oncol. 32:153–157. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pluciennik E, Nowakowska M, Wujcicka WI,
et al: Genetic alterations of WWOX in Wilms' tumor are
involved in its carcinogenesis. Oncol Rep. 28:1417–1422. 2012.
|
|
13
|
Yendamuri S, Kuroki T, Trapasso F, et al:
WW domain containing oxidoreductase gene expression is altered in
non-small cell lung cancer. Cancer Res. 63:878–881. 2003.PubMed/NCBI
|
|
14
|
Saluda-Gorgul A, Seta K, Nowakowska M and
Bednarek AK: WWOX oxidoreductase - substrate and enzymatic
characterization. Z Naturforsch C. 66:73–82. 2011. View Article : Google Scholar
|
|
15
|
Aqeilan RI, Hagan JP, de Bruin A, et al:
Targeted ablation of the WW domain-containing oxidoreductase tumor
suppressor leads to impaired steroidogenesis. Endocrinology.
150:1530–1535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aderca I, Moser CD, Veerasamy M, et al:
The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced
by the tumor suppressor WWOX. J Hepatol. 49:373–383. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hu BS, Tan JW, Zhu GH, Wang DF, Zhou X and
Sun ZQ: WWOX induces apoptosis and inhibits proliferation of human
hepatoma cell line SMMC-7721. World J Gastroenterol. 18:3020–3026.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuroki T, Yendamuri S, Trapasso F, et al:
The tumor suppressor gene WWOX at FRA16D is involved in pancreatic
carcinogenesis. Clin Cancer Res. 10:2459–2465. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qin HR, Iliopoulos D, Semba S, et al: A
role for the WWOX gene in prostate cancer. Cancer Res.
66:6477–6481. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matteucci E, Bendinelli P and Desiderio
MA: Nuclear localization of active HGF receptor Met in aggressive
MDA-MB231 breast carcinoma cells. Carcinogenesis. 30:937–945. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aqeilan RI, Donati V, Palamarchuk A, et
al: WW domain-containing proteins, WWOX and YAP, compete for
interaction with ErbB-4 and modulate its transcriptional function.
Cancer Res. 65:6764–6772. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gourley C, Paige AJ, Taylor KJ, et al:
WWOX gene expression abolishes ovarian cancer tumorigenicity in
vivo and decreases attachment to fibronectin via integrin alpha3.
Cancer Res. 69:4835–4842. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewandowska U, Zelazowski M, Seta K,
Byczewska M, Pluciennik E and Bednarek AK: WWOX, the tumour
suppressor gene affected in multiple cancers. J Physiol Pharmacol.
60(Suppl 1): 47–56. 2009.PubMed/NCBI
|
|
24
|
Bednarek AK, Keck-Waggoner CL, Daniel RL,
et al: WWOX, the FRA16D gene, behaves as a suppressor of tumor
growth. Cancer Res. 61:8068–8073. 2001.PubMed/NCBI
|
|
25
|
Pfaffl MW, Horgan GW and Dempfle L:
Relative expression software tool (REST) for group-wise comparison
and statistical analysis of relative expression results in
real-time PCR. Nucleic Acids Res. 30:e362002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harada T, Kaponis A, Iwabe T, et al:
Apoptosis in human endometrium and endometriosis. Hum Reprod
Update. 10:29–38. 2004. View Article : Google Scholar
|
|
27
|
Kokawa K, Shikone T, Otani T, et al:
Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and
adenocarcinoma of the uterine endometrium. Hum Reprod.
16:2211–2218. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Geisler JP, Geisler HE, Wiemann MC, Zhou
Z, Miller GA and Crabtree W: Lack of bcl-2 persistence: an
independent prognostic indicator of poor prognosis in endometrial
carcinoma. Gynecol Oncol. 71:305–307. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saegusa M and Okayasu I: Bcl-2 is closely
correlated with favorable prognostic factors and inversely
associated with p53 protein accumulation in endometrial carcinomas:
immunohistochemical and polymerase chain reaction/loss of
heterozygosity findings. J Cancer Res Clin Oncol. 123:429–434.
1997. View Article : Google Scholar
|
|
30
|
Chao H, Sun J and Lu S: Bax gene
expression in endometrial carcinoma. Zhonghua Zhong Liu Za Zhi.
23:214–216. 2001.(In Chinese).
|
|
31
|
Xiong Z, Hu S and Wang Z: Cloning of WWOX
gene and its growth-inhibiting effects on ovarian cancer cells. J
Huazhong Univ Sci Technolog Med Sci. 30:365–369. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
KEGG Database. http://www.genome.jp/kegg-bin/show_pathway?ko05213+K045032013.
Accessed 03.10.2013
|
|
33
|
Ruhul Quddus M, Latkovich P, Castellani
WJ, et al: Expression of cyclin D1 in normal, metaplastic,
hyperplastic endometrium and endometrioid carcinoma suggests a role
in endometrial carcinogenesis. Arch Pathol Lab Med. 126:459–463.
2002.
|
|
34
|
Moreno-Bueno G, Rodriguez-Perales S,
Sanchez-Estevez C, et al: Cyclin D1 gene (CCND1) mutations in
endometrial cancer. Oncogene. 22:6115–6118. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li H, Leo C, Schroen DJ and Chen JD:
Characterization of receptor interaction and transcriptional
repression by the corepressor SMRT. Mol Endocrinol. 11:2025–2037.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Moreno-Bueno G, Sanchez-Estevez C, Cassia
R, et al: Differential gene expression profile in endometrioid and
nonendometrioid endometrial carcinoma: STK15 is frequently
overexpressed and amplified in nonendometrioid carcinomas. Cancer
Res. 63:5697–5702. 2003.
|
|
37
|
Kershah SM, Desouki MM, Koterba KL and
Rowan BG: Expression of estrogen receptor coregulators in normal
and malignant human endometrium. Gynecol Oncol. 92:304–313. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Girault I, Lerebours F, Amarir S, et al:
Expression analysis of estrogen receptor alpha coregulators in
breast carcinoma: evidence that NCOR1 expression is predictive of
the response to tamoxifen. Clin Cancer Res. 9:1259–1266.
2003.PubMed/NCBI
|
|
39
|
Yi TZ, Guo J, Zhou L, et al: Prognostic
value of E-cadherin expression and CDH1 promoter methylation in
patients with endometrial carcinoma. Cancer Invest. 29:86–92. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang JQ, Li L, Song HL, Paige A and Gabra
H: Effect of WWOX gene on the attachment and adhesion of ovarian
cancer cells. Zhonghua Fu Chan Ke Za Zhi. 44:529–532. 2009.(In
Chinese).
|
|
41
|
Kuroki T, Trapasso F, Shiraishi T, et al:
Genetic alterations of the tumor suppressor gene WWOX in esophageal
squamous cell carcinoma. Cancer Res. 62:2258–2260. 2002.PubMed/NCBI
|
